Hodgkin Lymphoma - Relapsed/Refractory
Sort by:
Yale Cancer Center
Latest Advances in HL and PTCL Treatments
FEATURING
Tarsheen Sethi
- 38 views
- May 15, 2024
Indy Hematology Review
Emerging and Current Treatment for Hodgkin Lymphoma in 2024
FEATURING
Stephen M. Ansell
- 411 views
- April 23, 2024
- 5
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Hodgkin Lymphoma
FEATURING
Alex Herrera
- 68 views
- March 22, 2024
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in Management of Hodgkin Lymphoma
FEATURING
Jakub Svoboda
- 123 views
- March 13, 2024
City of Hope
Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Targeted Strategies
FEATURING
Idoroenyi Amanam
- 225 views
- March 11, 2024
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
The Potential Role of ctDNA in Hodgkin Lymphoma Management
FEATURING
Irina Panovska-Stavridis
- 42 views
- February 21, 2024
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Hodgkin Lymphoma: History and Current Management
FEATURING
Carmino De Souza
- 44 views
- February 21, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Long-Term Outcomes of AlloSCT for R/R HL & NHL: Multi-Center Experince From Turkey
FEATURING
Ayşe Uysal
- 7 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Current Treatments in Relapsed HL
FEATURING
Ganiye BegüL KüPeli
- 36 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Hodgkin Disease: Current Radiation Oncology Approach
FEATURING
Fulya Yaman Ağaoğlu
- 33 views
- February 15, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic Hodgkin Lymphoma"
FEATURING
Sanjal Desai
- 93 views
- December 29, 2023
- 1
Insights from 2023 ASH Annual Meeting
Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Doses
FEATURING
Daniel Wolff
- 122 views
- December 29, 2023
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PROs From BMT CTN 1703 Study in GVHD Prophylaxis - a QoL Evaluation"
FEATURING
Shernan Holtan
- 29 views
- December 22, 2023
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment of Older Patients With HL in the Modern Era"
FEATURING
Andrew Evens
- 154 views
- December 19, 2023
- 2
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Optimal Management of R/R cHL - Post-Brentuximab & Checkpoint Inhibitor Failure"
FEATURING
Natalie Grover
- 28 views
- December 15, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Manage Hodgkin Lymphoma
FEATURING
Amanda Cashen
- 42 views
- December 1, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Current Management of Hodgkin Lymphoma in Europe
FEATURING
Antonello Pinto
- 41 views
- December 1, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: HL
FEATURING
Alex Herrera
- 126 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Treatment of HL in Older Adults
FEATURING
Jonathan Friedberg
- 69 views
- October 19, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Response Adapted Therapy in cHL
FEATURING
Catherine Diefenbach
- 30 views
- October 17, 2023